Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Christina Falcon"'
Autor:
Satoshi Yoda, Wafa Malik, Adam Langenbucher, Justin F. Gainor, Sai-Hong Ignatius Ou, Kylie Prutisto-Chang, Ramin Sakhtemani, Jennifer L Peterson, Aaron N. Hata, Alexander Drilon, Andrew Do, Jessica J. Lin, Adam J. Schoenfeld, Viola W. Zhu, Ted William Johnson, Jochen K. Lennerz, Lecia V. Sequist, Noura J. Choudhury, Ibiayi Dagogo-Jack, Subba R. Digumarthy, Christina Falcon, Charlotte E. Lee, Alice T. Shaw, Michael S. Lawrence, Beow Y. Yeap, Jennifer S. Temel, Harper Hubbeling
Publikováno v:
Clin Cancer Res
Purpose: Current standard initial therapy for advanced, ROS proto-oncogene 1, receptor tyrosine kinase fusion (ROS1)-positive (ROS1+) non–small cell lung cancer (NSCLC) is crizotinib or entrectinib. Lorlatinib, a next-generation anaplastic lymphoma
Autor:
Jordan Dienstag, Olivia Wilkins, Jason C. Chang, Christina Falcon, Robin Guo, Maria E. Arcila, Glenn Heller, Charles M. Rudin, Bob T. Li, John K. Lyo, Michael Offin, Gregory J. Riely, Jia Luo, Paul K. Paik, Natasha Rekhtman, Alexander Drilon, Marc Ladanyi, Mark G. Kris
Publikováno v:
JCO Precision Oncology. :871-876
PURPOSE Although MET exon 14 ( METex14)–altered lung cancers were first identified more than a decade and a half ago, the frequency of CNS metastatic disease remains poorly defined. Furthermore, the seminal trial of crizotinib in these patients (PR
Autor:
Abraham J. Wu, V. Rusch, Andreas Rimner, Bernard J. Park, Harper Hubbeling, E. Ziv, Charles B. Simone, Daniel R. Gomez, Christina Falcon, Annemarie F. Shepherd, A. Drilon, Daphna Y. Gelblum, Narek Shaverdian, Noura J. Choudhury
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 111:e438-e439
Purpose/Objective(s) Local therapy (LTX) prolongs progression-free and overall survival (OS) in patients with oligometastatic non-small cell lung cancer. We previously reported substantial LTX benefit in time to progression or next therapy (TTP/TTNT)